Purpose: The aims of this randomized clinical trial are:
1. to assess scar quality from the patient and surgeon perspectives
2. to assess patient comfort in the days immediately following surgery
3. to assess the time taken to complete closure in the operating room.
4. the financial benefit or cost for the institution of using Steri Strip S will also be
Two closure methods will be compared, a new coaptive film device (Steri Strip S) versus
standard subcuticular sutures. The linear incisions will include the standard incision
segments utilized for an inverted-T closure for bilateral breast reduction and the
transabdominal incision segments utilized for abdominoplasty or TRAM flap harvest.
Our hypothesis is that incisions segments closed with Steri Strip S compared to standard
subcuticular closure, will yield scars of better cosmetic quality, in shorter time to
closure, with novice and expert surgeons, for both bilateral breast reduction and
abdominoplasty surgical procedures.
- Patients are eligible for enrollment if they agree to provide informed consent, are
at least 18 years of age, in generally good health, and available for follow-up in
the 5-7 month time frame.
- Women known to be pregnant, minors, patients potentially incompetent to provide
informed consent or complete the surveys described in our protocol will be excluded
from this trial.